Base Year
Historical Year
Forecast Year
Oncology precision medicine modifies cancer treatments according to an individual's genetic profile to improve efficacy and reduce side effects. The growing prevalence of cancer around the world and the acceptance of biomarker-based tests have created a significant impact on the market value. Innovations such as next-generation sequencing and liquid biopsies are improving diagnosis and treatment modalities. Other innovations, coupled with enhanced investments, have increased market growth and reshaped the cancer management scenario worldwide.
Rising Prevalence of Cancer Incidence Drives Market Growth
The increasing prevalence of cancer globally is driving the demand for precision medicine that offers more advanced and effective treatments compared to standard methods. According to the American Cancer Society, it was estimated that there would be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. The expanding number of patients is emphasizing the requirement for precision medicine, which can enhance the treatment process and thus speed up the growth of the market.
Several trends and developments are being observed in the market to enhance the current situation. The following are some of the noteworthy trends.
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Cancer Type
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on the Cancer Type Set to Witness Substantial Growth
Based on cancer type, the market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, skin cancer and others. Among these, breast cancer is expected to dominate the market because of its widespread global occurrence and the growing emphasis on targeted therapy solutions. Gene therapies for breast cancer target particular genetic mutations, providing personalized and efficient treatments.
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America is expected to lead the market share, owing to high cancer prevalence and increasing advancements in healthcare innovation in the region. Furthermore, a strong healthcare infrastructure, including established healthcare systems, and hospitals, also plays a significant role in driving market growth.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Based in New York and a top provider in the realm of precision medicine for oncology, Bristol-Myers Squibb creates various kinds of drugs, one of which is Opdivo (nivolumab). Opdivo is a medication that works by engaging with the PD-1 receptor to enhance the body's ability to recognize and eliminate cancerous cells.
Illumina, Inc., headquartered in San Diego, California, is a top developer of sequencing and array-based solut...
The company was established in the city of New York in the year 1849. Their product portfolio includes treatme...
Novartis AG is an international pharmaceutical company headquartered in Basel, Switzerland. The company's focu...
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Roche Holding AG, Thermo Fisher Scientific, Inc., AstraZeneca plc, Guardant Health, Inc., Exact Sciences Corporation, and Caris Life Sciences.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Cancer Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share